News | October 31, 2022
Sustaining growth momentum is key for Navin Fluorine: ICICI Securities
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities
The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
The initiative will engage adolescents and youth of India in decisions about their reproductive health
The company confirms an upward revision to its 2021 Outlook, reflecting the expectation to achieve mid-teens CER sales growth
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
Net profit doubled to Rs. 10.8 crore, with PAT margin expanding by 560 bps to 14.3%, reflecting strong operational execution
Subscribe To Our Newsletter & Stay Updated
